FDA Approves Boston Scientific’s SYNERGY BP Stent For High Bleeding Risk Patients
The bioabsorbable polymer-coated, sirolimus-eluting stent is the first drug-eluting stent approved for this population.

The bioabsorbable polymer-coated, sirolimus-eluting stent is the first drug-eluting stent approved for this population.